Radiation recall dermatitis and pneumonitis induced by trastuzumab (Herceptin®)

International Journal of Dermatology

Volumn 53, Issue 3, 2014, Pages

  Lee, Hae Eul ^a   Jeong, Nam Ji ^a   Lee, Young ^a   Seo, Young Joon ^a   Kim, Chang Deok ^a   Lee, Jeung Hoon ^a   Im, Myung ^a  

^a Chungnam National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY; TRASTUZUMAB;

BREAST NEOPLASMS; CASE REPORT; CHEMICALLY INDUCED; FEMALE; FIBROADENOMA; HUMAN; MIDDLE AGED; PNEUMONIA; RADIATION DERMATITIS;

ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; FEMALE; FIBROADENOMA; HUMANS; MIDDLE AGED; PNEUMONIA; RADIODERMATITIS;

EID: 84894241368     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2012.05788.x     Document Type: Letter

References (8)

1. Camidge R, Price A. Characterizing the phenomenon of radiation recall dermatitis. Radiother Oncol 2001; 59: 237-245.
2. Kaya TI, Tiftik N, Tursen U, Ikizoglu G. Ultraviolet recall phenomenon associated with methotrexate and cytarabine. JEADV 2006; 20: 353-354.
3. Shrimali RK, McPhail NJ, Correa PD. Trastuzumab-induced radiation recall dermatitis - first reported case. Oncology 2000; 12: 272-273.
4. Chung C, Stuart D, Keyes M. Radiation recall reaction induced by adjuvant trastuzumab (herceptin). Case Report Med 2009; 2009: 307894.
5. Burris HA III, Hurtig J. Radiation recall with anticancer agents. Oncologist 2010; 15: 1227-1237.
6. Schweitzer VG, Juillard GJF, Bajada CL. Radiation recall dermatitis and pneumonitis in a patient treated with Paclitaxel. Cancer 1995; 76: 1069-1072.
7. Harries M, Smith I. The development and clinical use of trastuzumab (Herceptin). Endocr Relat Cancer 2002; 9: 75-85.
8. Yeo W, Leung SF, Johnson PJ. Radiation-recall dermatitis with docetaxel: establishment of a requisite radiation threshold. Eur J Cancer 1997; 33: 698-699.